Stocks
Intellia Therapeutics (NTLA) Revenue US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Revenue, bln rub | ? | 43.1 | 58.0 | 33.1 | 52.1 | 36.3 | 46.9 | ||
| Changes by years, y/y, % | +42% | +35% | -43% | +58% | -30% | +3.6% | |||
Intellia Therapeutics. Revenue US GAAP, bln rub
Intellia Therapeutics. Revenue US GAAP, changes, %
Intellia Therapeutics. Revenue US GAAP, sum by quarters, bln rub
Intellia Therapeutics (NTLA) Revenue US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Revenue, bln rub | ? | 12.0 | 1.92 | 28.9 | 6.96 | 9.11 | 46.9 | |
| Changes by years, y/y, % | -10% | -86% | +130% | -49% | -24% | |||
| Changes by quarters, q/q, % | -12% | -84% | +1 409% | -76% | +31% | |||
